Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 19, 2018
Rentschler Fill Solutions GmbH has inaugurated its new state-of-the-art facility in Rankweil, Austria.
read more
Rentschler Fill Solutions GmbH announced the appointment of Dr. Friedrich Sernetz as Chief Executive Officer.
read more
Wednesday, October 04, 2017
Rentschler Biotechnologie GmbH announced the company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017.
read more
Rentschler Biotechnologie GmbH, a CDMO for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, have announced a strategic partnership to provide new state-of-the-art fill and finish ...
read more
Wednesday, September 13, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that it has received the cGMP Manufacturing Compliance Certificate, ...
read more
Vetter and Rentschler Biopharma have announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.
read more
Wednesday, January 31, 2018
Rentschler Biopharma SE has appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February 1, 2018.
read more
Rentschler Biopharma SE announced that the company’s new state-of-the-art production line, formerly known as the Rentschler Biopharma Manufacturing Center (RBMC), in Milford, MA in the U.S. is now fully operational.
read more
Wednesday, December 20, 2023
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major client collaboration for its upcoming Rentschler Biopharma Manufacturing Center (RBMC) ...
read more
Rentschler Biopharma announced Prof. Dr. Nikolaus F. Rentschler, and CEO Dr. Frank Mathias have received the "EY Entrepreneur of the Year" Award 2019 in the category Industry.
read more
Rentschler Biopharma and Horizon Discovery announced the signing of a commercial license agreement.
read more
Tuesday, September 03, 2024
Rentschler Biopharma SE announced the launch of an expanded service offering at its dedicated advanced therapies site in Stevenage, UK. This enhancement introduces a new lentiviral vector manufacturing (LVV) toolbox, complementing the company’s ...
read more
Wednesday, March 28, 2018
Rentschler Biopharma SE announced Dr. Thomas Rösch will join the company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.
read more
Thursday, February 03, 2022
Rentschler Biopharma announced that the company has further strengthened its Leadership Team with the hiring of several senior level, highly experienced biopharmaceutical executives.
read more
Rentschler Biopharma has entered into a collaboration with Genmab for the development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform.
read more